Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels

Helen Anderson, Naomi Fogel, Stefan K. Grebe, Ravinder Jit Singh, Robert L. Taylor, Andrea Dunaif

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Context: Prenatal androgen excess can cause a phenocopy of polycystic ovary syndrome (PCOS) in mammals. Retrospective studies have suggested that girls at risk for PCOS have low birth weight, and prospective studies have suggested an increased prevalence of small-for-gestational-age offspring in women with PCOS. Objective: The objective of the study was to determine whether infants of women with PCOS have reduced birth weight or increased intrauterine androgen levels. Design: This was a prospective case-control study. Participants: Thirty-nine PCOS and 31 control women and their infants participated in the study. Main Outcome Measures: Birth weight and mixed cord blood testosterone, androstenedione (A), dehydroepiandrosterone, 17-hydroxyprogesterone, estradiol (E2), and dihydrotestosterone levels were measured. Results: Mean birth weight did not differ, but there was a significant increase in the prevalence of large-for-gestational-age infants in the PCOS group. Cord blood E2 and A levels were lower (P < 0.05), but testosterone to E2 ratios did not differ in female PCOS compared with control offspring. There was no difference in E2 and A levels in the male PCOS and control offspring. There was no difference in 17-hydroxyprogesterone or other androgen levels in either male or female PCOS offspring compared with their respective control group. Conclusion: Infants of women with PCOS were more likely to be large for gestational age. Female offspring of affected women have lower cord blood A levels; other cord blood androgen levels do not differ compared with female control offspring. Cord blood E2 levels are also significantly decreased in PCOS, without any difference in the testosterone to E2 ratio, suggesting decreased fetal or placental production of steroids.

Original languageEnglish (US)
Pages (from-to)2180-2186
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume95
Issue number5
DOIs
StatePublished - May 2010

Fingerprint

Androstenedione
Polycystic Ovary Syndrome
Fetal Blood
Estradiol
Blood
Androgens
17-alpha-Hydroxyprogesterone
Testosterone
Birth Weight
Gestational Age
Mammals
Units of measurement
Dehydroepiandrosterone
Dihydrotestosterone
Steroids
Low Birth Weight Infant
Case-Control Studies
Retrospective Studies
Outcome Assessment (Health Care)
Prospective Studies

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Endocrinology
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. / Anderson, Helen; Fogel, Naomi; Grebe, Stefan K.; Singh, Ravinder Jit; Taylor, Robert L.; Dunaif, Andrea.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 95, No. 5, 05.2010, p. 2180-2186.

Research output: Contribution to journalArticle

Anderson, Helen ; Fogel, Naomi ; Grebe, Stefan K. ; Singh, Ravinder Jit ; Taylor, Robert L. ; Dunaif, Andrea. / Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels. In: Journal of Clinical Endocrinology and Metabolism. 2010 ; Vol. 95, No. 5. pp. 2180-2186.
@article{3502f5bdb2d042d788455da4faf68c12,
title = "Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels",
abstract = "Context: Prenatal androgen excess can cause a phenocopy of polycystic ovary syndrome (PCOS) in mammals. Retrospective studies have suggested that girls at risk for PCOS have low birth weight, and prospective studies have suggested an increased prevalence of small-for-gestational-age offspring in women with PCOS. Objective: The objective of the study was to determine whether infants of women with PCOS have reduced birth weight or increased intrauterine androgen levels. Design: This was a prospective case-control study. Participants: Thirty-nine PCOS and 31 control women and their infants participated in the study. Main Outcome Measures: Birth weight and mixed cord blood testosterone, androstenedione (A), dehydroepiandrosterone, 17-hydroxyprogesterone, estradiol (E2), and dihydrotestosterone levels were measured. Results: Mean birth weight did not differ, but there was a significant increase in the prevalence of large-for-gestational-age infants in the PCOS group. Cord blood E2 and A levels were lower (P < 0.05), but testosterone to E2 ratios did not differ in female PCOS compared with control offspring. There was no difference in E2 and A levels in the male PCOS and control offspring. There was no difference in 17-hydroxyprogesterone or other androgen levels in either male or female PCOS offspring compared with their respective control group. Conclusion: Infants of women with PCOS were more likely to be large for gestational age. Female offspring of affected women have lower cord blood A levels; other cord blood androgen levels do not differ compared with female control offspring. Cord blood E2 levels are also significantly decreased in PCOS, without any difference in the testosterone to E2 ratio, suggesting decreased fetal or placental production of steroids.",
author = "Helen Anderson and Naomi Fogel and Grebe, {Stefan K.} and Singh, {Ravinder Jit} and Taylor, {Robert L.} and Andrea Dunaif",
year = "2010",
month = "5",
doi = "10.1210/jc.2009-2651",
language = "English (US)",
volume = "95",
pages = "2180--2186",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Infants of women with polycystic ovary syndrome have lower cord blood androstenedione and estradiol levels

AU - Anderson, Helen

AU - Fogel, Naomi

AU - Grebe, Stefan K.

AU - Singh, Ravinder Jit

AU - Taylor, Robert L.

AU - Dunaif, Andrea

PY - 2010/5

Y1 - 2010/5

N2 - Context: Prenatal androgen excess can cause a phenocopy of polycystic ovary syndrome (PCOS) in mammals. Retrospective studies have suggested that girls at risk for PCOS have low birth weight, and prospective studies have suggested an increased prevalence of small-for-gestational-age offspring in women with PCOS. Objective: The objective of the study was to determine whether infants of women with PCOS have reduced birth weight or increased intrauterine androgen levels. Design: This was a prospective case-control study. Participants: Thirty-nine PCOS and 31 control women and their infants participated in the study. Main Outcome Measures: Birth weight and mixed cord blood testosterone, androstenedione (A), dehydroepiandrosterone, 17-hydroxyprogesterone, estradiol (E2), and dihydrotestosterone levels were measured. Results: Mean birth weight did not differ, but there was a significant increase in the prevalence of large-for-gestational-age infants in the PCOS group. Cord blood E2 and A levels were lower (P < 0.05), but testosterone to E2 ratios did not differ in female PCOS compared with control offspring. There was no difference in E2 and A levels in the male PCOS and control offspring. There was no difference in 17-hydroxyprogesterone or other androgen levels in either male or female PCOS offspring compared with their respective control group. Conclusion: Infants of women with PCOS were more likely to be large for gestational age. Female offspring of affected women have lower cord blood A levels; other cord blood androgen levels do not differ compared with female control offspring. Cord blood E2 levels are also significantly decreased in PCOS, without any difference in the testosterone to E2 ratio, suggesting decreased fetal or placental production of steroids.

AB - Context: Prenatal androgen excess can cause a phenocopy of polycystic ovary syndrome (PCOS) in mammals. Retrospective studies have suggested that girls at risk for PCOS have low birth weight, and prospective studies have suggested an increased prevalence of small-for-gestational-age offspring in women with PCOS. Objective: The objective of the study was to determine whether infants of women with PCOS have reduced birth weight or increased intrauterine androgen levels. Design: This was a prospective case-control study. Participants: Thirty-nine PCOS and 31 control women and their infants participated in the study. Main Outcome Measures: Birth weight and mixed cord blood testosterone, androstenedione (A), dehydroepiandrosterone, 17-hydroxyprogesterone, estradiol (E2), and dihydrotestosterone levels were measured. Results: Mean birth weight did not differ, but there was a significant increase in the prevalence of large-for-gestational-age infants in the PCOS group. Cord blood E2 and A levels were lower (P < 0.05), but testosterone to E2 ratios did not differ in female PCOS compared with control offspring. There was no difference in E2 and A levels in the male PCOS and control offspring. There was no difference in 17-hydroxyprogesterone or other androgen levels in either male or female PCOS offspring compared with their respective control group. Conclusion: Infants of women with PCOS were more likely to be large for gestational age. Female offspring of affected women have lower cord blood A levels; other cord blood androgen levels do not differ compared with female control offspring. Cord blood E2 levels are also significantly decreased in PCOS, without any difference in the testosterone to E2 ratio, suggesting decreased fetal or placental production of steroids.

UR - http://www.scopus.com/inward/record.url?scp=77952747569&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952747569&partnerID=8YFLogxK

U2 - 10.1210/jc.2009-2651

DO - 10.1210/jc.2009-2651

M3 - Article

C2 - 20228162

AN - SCOPUS:77952747569

VL - 95

SP - 2180

EP - 2186

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -